{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:30:51Z","timestamp":1761597051733},"reference-count":24,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Enzyme-linked immunosorbent assay (ELISA) and related assays are representative of methods currently used for antibody tests. However, they occasionally produce nonspecific reactions, thus making it difficult to reliably measure low levels of specific antibodies. To find a test method that minimizes nonspecific reactions, we introduced the principle of antibody-mediated complement-dependent cytotoxicity (CDC) into an antibody assay. The procedure has three steps: (i) the mixing of test samples with a suspension of cells expressing the antigen of interest on their surfaces, (ii) the addition of rabbit complement, and (iii) the measurement of lactose dehydrogenase (LDH) activities by adding a chromogenic substrate to the reaction mixture. When the specific antibodies exist in the sample, complement activation triggered by antibody binding on the surface of the antigen-expressing cells may lyse the cells, releasing LDH into the medium. Mouse and rabbit sera hyperimmune to nonstructural protein 1 (NS1) of Japanese encephalitis virus (JEV) lysed NS1-expressing cells in a dose-dependent manner. Evaluations using sera from horses naturally infected with JEV showed that the CDC assay had quantitative correlation and qualitative agreement with previously established NS1 antibody-detecting immunostaining and ELISA methods. The assay method also detected NS1 antibodies in sera of mice 2 days after experimental infection with JEV; specific, but not natural, immunoglobulin M antibodies were detected. Since almost all sera examined in this study showed no nonspecific reactions, the CDC assay was shown to be a reliable method for measuring low levels of specific antibodies.<\/jats:p>","DOI":"10.1128\/cvi.00347-07","type":"journal-article","created":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T02:06:34Z","timestamp":1195697194000},"page":"88-94","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Utilization of Complement-Dependent Cytotoxicity To Measure Low Levels of Antibodies: Application to Nonstructural Protein 1 in a Model of Japanese Encephalitis Virus"],"prefix":"10.1128","volume":"15","author":[{"given":"Eiji","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Kobe University School of Medicine, Kobe"},{"name":"Epizootic Research Center, Equine Research Institute, Japan Racing Association, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Kobe University School of Medicine, Kobe"},{"name":"Epizootic Research Center, Equine Research Institute, Japan Racing Association, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Kobe University School of Medicine, Kobe"},{"name":"Epizootic Research Center, Equine Research Institute, Japan Racing Association, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"553","volume":"58","year":"1986","unstructured":"Boere, W. A., B. J. Benaissa-Trouw, T. Harmsen, T. Erich, C. A. Kraaijeveld, and H. Snippe. 1986. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus. Immunology58:553-559.","journal-title":"Immunology"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.3.1340-1351.2006"},{"key":"e_1_3_2_4_2","unstructured":"Current protocols in immunology. 1996"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.9.4356-4363.1990"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.35.1.248-255.1982"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2000.imr017520.x","volume":"175","year":"2000","unstructured":"Herzenberg, L. A. 2000. B-1 cells: the lineage question revisited. Immunol. Rev.175:9-22.","journal-title":"Immunol. Rev."},{"key":"e_1_3_2_8_2","first-page":"411","volume":"31","year":"1990","unstructured":"Inoue, Y., Y. Ohashi, Y. Shimomura, R. Manabe, M. Yamada, S. Ueda, and S. Kato. 1990. Herpes simplex virus glycoprotein D. Protective immunity against murine herpetic keratitis. Investig. Ophthalmol. Vis. Sci.31:411-418.","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1099\/0022-1317-75-9-2399","volume":"75","year":"1994","unstructured":"Jacobs, S. C., J. R. Stephenson, and G. W. G. Wilkinson. 1994. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. J. Gen. Virol.75:2399-2402.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0065-2776(08)60663-X","volume":"47","year":"1989","unstructured":"Kipps, T. J. 1989. The CD5 B cell. Adv. Immunol.47:117-185.","journal-title":"Adv. Immunol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00051-07"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0031182097001509","volume":"115","year":"1997","unstructured":"Konishi, E. 1997. Monoclonal antibodies multireactive with parasite antigens produced by hybridomas generated from naive mice. Parasitology115:387-393.","journal-title":"Parasitology"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.11.5087-5093.2004"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.vaccine.2003.10.001","volume":"22","year":"2004","unstructured":"Konishi, E., M. Shoda, and T. Kondo. 2004. Prevalence of antibody to Japanese encephalitis virus nonstructural 1 protein among racehorses in Japan: indication of natural infection and need for continuous vaccination. Vaccine22:1097-1103.","journal-title":"Vaccine"},{"key":"e_1_3_2_15_2","first-page":"98","volume":"22","year":"2002","unstructured":"Konishi, E., and T. Suzuki. 2002. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvaccinated populations. Vaccine22:98-107.","journal-title":"Vaccine"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.5527-5534.1999"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.1.191-200.1998"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0531-5565(02)00011-6","volume":"37","year":"2002","unstructured":"Massari, I., A. Donnini, K. Argentati, S. Straino, A. Mangoni, C. Gaetano, C. Viticchi, M. Capogrossi, and M. Provinciali. 2002. Age-dependent effects of repeated immunization with a first generation adenovirus vector on the immune response and transgene expression in young and old rats. Exp. Gerontol.37:823-831.","journal-title":"Exp. Gerontol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.150.8.3421","volume":"150","year":"1993","unstructured":"McLain, L., and N. J. Dimmock. 1993. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen. J. Immunol.150:3421-3426.","journal-title":"J. Immunol."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.60.3.1153-1155.1986"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1993.1015","volume":"192","year":"1993","unstructured":"Schlesinger, J. J., M. Foltzer, and S. Chapman. 1993. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology192:132-141.","journal-title":"Virology"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0264-410X(00)00391-1","volume":"19","year":"2001","unstructured":"Shu, P. Y., L. K. Chen, S. F. Chang, Y. Y. Yueh, L. Chow, L. J. Chien, C. Chin, T. H. Lin, and J. H. Huang. 2001. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine19:1753-1763.","journal-title":"Vaccine"},{"key":"e_1_3_2_23_2","first-page":"493","year":"2001","unstructured":"Storch, G. A. 2001. Diagnostic virology, p. 493-531. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","journal-title":"Fields virology"},{"key":"e_1_3_2_24_2","first-page":"28","volume":"61","year":"1997","unstructured":"West, K., and J. Ellis. 1997. Functional analysis of antibody responses of feedlot cattle to bovine respiratory syncytial virus following vaccination with mixed vaccines. Can. J. Vet. Res.61:28-33.","journal-title":"Can. J. Vet. Res."},{"key":"e_1_3_2_25_2","first-page":"285","year":"2001","unstructured":"Whitton, J. L., and M. B. A. Oldstone. 2001. The immune response to viruses, p. 285-320. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","journal-title":"Fields virology"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00347-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00347-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T21:55:37Z","timestamp":1684101337000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00347-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1128\/CVI.00347-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00347-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"2007-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-11-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}